Blue Trust Inc’s Regencell Bioscience RGC Stock Holding History

Blue Trust Inc’s Portfolio RGC Stock Details RGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-216	Closed	-$1.32K	–	2722
2026 Q2	$1.32K	Hold	216	–	–	﹤0.01%	2255
2026 Q1	$5.49K	Hold	216	–	–	﹤0.01%	1969
2025 Q4	$4.54K	Buy	+216	New	+$3.51K	﹤0.01%	2009

Other funds holding RGC

Mainstream Capital Management Los Angeles, California $170M AUM 21% 1-Year Est. Return

Blue Trust Inc's RGC Position: Q3 2026 in Review

Blue Trust Inc sold out of Regencell Bioscience (RGC) in Q3 2026, closing a stake of 216 shares — an estimated $1.32K sold.

Blue Trust Inc first reported a position in RGC in Q4 2025 and held it in 3 quarters. The position peaked at $5.49K in Q1 2026. 1 fund tracked by Wall St. Rank holds RGC as of Q3 2026.

Blue Trust Inc reported no remaining Regencell Bioscience position as of Q3 2026 after selling out during the quarter.
Blue Trust Inc sold 216 Regencell Bioscience shares in Q3 2026, an estimated $1.32K.
Blue Trust Inc first reported a position in Regencell Bioscience in Q4 2025 and held it in 3 quarters.
Blue Trust Inc's Regencell Bioscience position peaked at $5.49K in Q1 2026.
1 fund tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.